108 related articles for article (PubMed ID: 25352318)
41. Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents.
Qian Y; Ma GY; Yang Y; Cheng K; Zheng QZ; Mao WJ; Shi L; Zhao J; Zhu HL
Bioorg Med Chem; 2010 Jun; 18(12):4310-6. PubMed ID: 20493717
[TBL] [Abstract][Full Text] [Related]
42. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK
Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233
[TBL] [Abstract][Full Text] [Related]
43. Development of a novel class of tubulin inhibitors with promising anticancer activities.
Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.
Prakasham AP; Saxena AK; Luqman S; Chanda D; Kaur T; Gupta A; Yadav DK; Chanotiya CS; Shanker K; Khan F; Negi AS
Bioorg Med Chem; 2012 May; 20(9):3049-57. PubMed ID: 22472045
[TBL] [Abstract][Full Text] [Related]
45. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
46. Indicine N-oxide binds to tubulin at a distinct site and inhibits the assembly of microtubules: a mechanism for its cytotoxic activity.
Appadurai P; Rathinasamy K
Toxicol Lett; 2014 Feb; 225(1):66-77. PubMed ID: 24300171
[TBL] [Abstract][Full Text] [Related]
47. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds.
Hyder I; Yedlapudi D; Kalivendi SV; Khazir J; Ismail T; Nalla N; Miryala S; Sampath Kumar HM
Bioorg Med Chem Lett; 2015 Jul; 25(14):2860-3. PubMed ID: 26022842
[TBL] [Abstract][Full Text] [Related]
49. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
[TBL] [Abstract][Full Text] [Related]
50. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
51. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
53. Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity.
Zhao W; Bai JK; Li HM; Chen T; Tang YJ
Sci Rep; 2015 May; 5():10172. PubMed ID: 25959922
[TBL] [Abstract][Full Text] [Related]
54. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
[TBL] [Abstract][Full Text] [Related]
55. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
56. Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studies.
Sharma S; Kaur C; Budhiraja A; Nepali K; Gupta MK; Saxena AK; Bedi PM
Eur J Med Chem; 2014 Oct; 85():648-60. PubMed ID: 25128667
[TBL] [Abstract][Full Text] [Related]
57. [Progress in the study of tubulin inhibitors].
Shang H; Pan L; Yang S; Chen H; Cheng MS
Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors.
Nakamura H; Kuroda H; Saito H; Suzuki R; Yamori T; Maruyama K; Haga T
ChemMedChem; 2006 Jul; 1(7):729-40. PubMed ID: 16902927
[TBL] [Abstract][Full Text] [Related]
59. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
60. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
